| Q27010785 | A window into the heterogeneity of human cerebrospinal fluid Aβ peptides |
| Q34067393 | Activation of TRPML1 clears intraneuronal Aβ in preclinical models of HIV infection |
| Q33858587 | Amyloid-beta fibrillogenesis seeded by interface-induced peptide misfolding and self-assembly |
| Q96438340 | Amyloid-β Oligomerization Monitored by Single-Molecule Stepwise Photobleaching |
| Q52612916 | Aβ42 oligomers, but not fibrils, simultaneously bind to and cause damage to ganglioside-containing lipid membranes. |
| Q34949156 | Binding, conformational transition and dimerization of amyloid-β peptide on GM1-containing ternary membrane: insights from molecular dynamics simulation |
| Q38646645 | Changes in lipid membranes may trigger amyloid toxicity in Alzheimer's disease |
| Q41771186 | Cholesterol accelerates the binding of Alzheimer's β-amyloid peptide to ganglioside GM1 through a universal hydrogen-bond-dependent sterol tuning of glycolipid conformation |
| Q36510536 | Condensing and fluidizing effects of ganglioside GM1 on phospholipid films |
| Q45585277 | DHPC Strongly Affects the Structure and Oligomerization Propensity of Alzheimer's Aβ(1–40) Peptide |
| Q42433961 | Designed Fluorescent Probes Reveal Interactions between Amyloid-β(1–40) Peptides and GM1 Gangliosides in Micelles and Lipid Vesicles |
| Q34117110 | Direct observation of defects and increased ion permeability of a membrane induced by structurally disordered Cu/Zn-superoxide dismutase aggregates. |
| Q36270027 | Europium as an inhibitor of Amyloid-β(1-42) induced membrane permeation |
| Q35870566 | Interaction of tau protein with model lipid membranes induces tau structural compaction and membrane disruption |
| Q85022573 | Lipid molecules induce the cytotoxic aggregation of Cu/Zn superoxide dismutase with structurally disordered regions |
| Q37896721 | Membrane and surface interactions of Alzheimer's Aβ peptide--insights into the mechanism of cytotoxicity |
| Q37847817 | Oxidative stress and cell membranes in the pathogenesis of Alzheimer's disease |
| Q51805155 | Polymorphic cross-seeding amyloid assemblies of amyloid-β and human islet amyloid polypeptide. |
| Q40896644 | PrP(106-126) does not interact with membranes under physiological conditions |
| Q40643878 | Raman spectroscopy for detecting supported planar lipid bilayers composed of ganglioside-GM1/sphingomyelin/cholesterol in the presence of amyloid-β. |
| Q51774769 | Real-time probing of β-amyloid self-assembly and inhibition using fluorescence self-quenching between neighbouring dyes. |
| Q57825213 | Reversible Cation-Selective Attachment and Self-Assembly of Human Tau on Supported Brain Lipid Membranes |
| Q36662671 | Role of ganglioside metabolism in the pathogenesis of Alzheimer's disease--a review |
| Q34007818 | Roles for dysfunctional sphingolipid metabolism in Alzheimer's disease neuropathogenesis |
| Q36149981 | Serum ceramides increase the risk of Alzheimer disease: the Women's Health and Aging Study II. |
| Q34213669 | Small amphipathic molecules modulate secondary structure and amyloid fibril-forming kinetics of Alzheimer disease peptide Aβ(1-42). |
| Q48748735 | The Level of NMDA Receptor in the Membrane Modulates Amyloid-β Association and Perforation |
| Q34493230 | The absence of myelin basic protein promotes neuroinflammation and reduces amyloid β-protein accumulation in Tg-5xFAD mice |